Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunopathogenesis and treatment of cytokine storm in COVID-19
Jae‐Seok Kim, Jun Young Lee, Jae Won Yang, et al.
Theranostics (2020) Vol. 11, Iss. 1, pp. 316-329
Open Access | Times Cited: 418

Showing 1-25 of 418 citing articles:

Pathogenesis and treatment of cytokine storm in COVID-19
Mehmet Soy, Gökhan Keser, Pamir Atagündüz
TURKISH JOURNAL OF BIOLOGY (2021) Vol. 45, Iss. SI-1, pp. 372-389
Open Access | Times Cited: 229
Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19
Moumita Manik, Rakesh Kumar Singh
Journal of Medical Virology (2021) Vol. 94, Iss. 3, pp. 869-877
Open Access | Times Cited: 137
The autonomic aspects of the post-COVID19 syndrome
Arad Dotan, Paula David, Dana Arnheim, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 5, pp. 103071-103071
Open Access | Times Cited: 108
The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections
Ren‐Jun Hsu, Wei-Chieh Yu, Guan-Ru Peng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 105
SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2
Katherine M. Littlefield, Renée O. Watson, Jennifer M. Schneider, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 5, pp. e1010359-e1010359
Open Access | Times Cited: 91
Classic Signaling Pathways in Alveolar Injury and Repair Involved in Sepsis-Induced ALI/ARDS: New Research Progress and Prospect
Wenli Li, Duo Li, Yuansen Chen, et al.
Disease Markers (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 78
Autoimmune and Autoinflammatory Connective Tissue Disorders Following COVID-19
Sung Ha Lim, Hyun Jeong Ju, Ju Hee Han, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2336120-e2336120
Open Access | Times Cited: 67
COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction
Ekaterina Georgieva, Julian Ananiev, Y. Yovchev, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14876-14876
Open Access | Times Cited: 58
Emerging aspects of cytokine storm in COVID-19: The role of proinflammatory cytokines and therapeutic prospects
Renu Dharra, Añil Sharma, Sonal Datta
Cytokine (2023) Vol. 169, pp. 156287-156287
Open Access | Times Cited: 53
The roles of critical pro‐inflammatory cytokines in the drive of cytokine storm during SARS‐CoV‐2 infection
Muhammad Suhaib Qudus, Mingfu Tian, Summan Sirajuddin, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Open Access | Times Cited: 50
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus
Inés Valencia, Jairo Lumpuy‐Castillo, Giselle Santos Magalhães, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 20
A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response
Yinghua Zhao, Liyan Sui, Ping Wu, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 90
Pathogenesis and Treatment of Cytokine Storm Induced by Infectious Diseases
Xidian Tang, Tiantian Ji, Jia-Rui Dong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 23, pp. 13009-13009
Open Access | Times Cited: 75
Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses
Ali A. Rabaan, Shamsah H. Al-Ahmed, Mohammed Garout, et al.
Pathogens (2021) Vol. 10, Iss. 5, pp. 565-565
Open Access | Times Cited: 73
Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
Adekunle Babajide Rowaiye, Okiemute Ajiroghene Okpalefe, Olukemi Onuh Adejoke, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 1487-1510
Open Access | Times Cited: 72
Neutrophil activation and neutrophil extracellular traps (NETs) in COVID‐19 ARDS and immunothrombosis
Maria Candida Cesta, Mara Zippoli, Carolina Marsiglia, et al.
European Journal of Immunology (2022) Vol. 53, Iss. 1
Open Access | Times Cited: 68
Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders
Roberta Giordo, Angelo Zinellu, Ali H. Eid, et al.
Molecules (2021) Vol. 26, Iss. 4, pp. 856-856
Open Access | Times Cited: 65
The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
Grażyna Sygitowicz, Agata Maciejak, Dariusz Sitkiewicz
Biomolecules (2021) Vol. 12, Iss. 1, pp. 46-46
Open Access | Times Cited: 65
The role of IL-6 in coronavirus, especially in COVID-19
Xinyi Wang, Guozheng Tang, Yuchen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 61
Qingwenzhike Prescription Alleviates Acute Lung Injury Induced by LPS via Inhibiting TLR4/NF-kB Pathway and NLRP3 Inflammasome Activation
Cai Zhang, Xinran Wang, Chunguo Wang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 58
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul, Luis Alberto Bravo-Vázquez, Paula Reyes‐Pérez, et al.
Virus Research (2021) Vol. 308, pp. 198631-198631
Open Access | Times Cited: 57
Role of SARS-CoV-2-induced cytokine storm in multi-organ failure: Molecular pathways and potential therapeutic options
Yasaman Nazerian, Mobina Ghasemi, Younes Yassaghi, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109428-109428
Open Access | Times Cited: 51
Peritoneal M2 macrophage-derived extracellular vesicles as natural multitarget nanotherapeutics to attenuate cytokine storms after severe infections
Yizhuo Wang, Shuyun Liu, Lan Li, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 118-132
Open Access | Times Cited: 44
Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions
Yujie Jiang, Tingmei Zhao, Xueyan Zhou, et al.
MedComm (2022) Vol. 3, Iss. 3
Open Access | Times Cited: 44
Modeling Heart Diseases on a Chip: Advantages and Future Opportunities
Omar Mourad, Ryan Yee, Mengyuan Li, et al.
Circulation Research (2023) Vol. 132, Iss. 4, pp. 483-497
Closed Access | Times Cited: 37
Page 1 - Next Page

Scroll to top